10|02|25

Unpacking the FDA’s Double Standard

In her latest op-ed for MM+M, Susan Perlbachs, Chief Creative Officer, delivers a powerful reflection on the FDA’s recent wave of untitled and warning letters—and the broader implications for how pharma is scrutinized compared to other industries. Read more.

09|30|25

EVERSANA INTOUCH Wins Agency of the Year Recognition

Tonight at Gotham Hall in New York City, the 17th annual PM360 Trailblazer Awards delivered an unforgettable celebration of innovation in life sciences marketing, and we’re honored to share that EVERSANA INTOUCH was named Company of the Year in the Advertising Agency category! 

09|25|25

Navigating the FDA’s DTC Crackdown: What Pharma Marketers Need to Know

The FDA’s recent wave of warning letters targeting direct-to-consumer (DTC) pharmaceutical advertising has sent ripples through the industry. While the agency’s actions may not make TV advertising impossible, they do signal a significant tightening of enforcement—particularly around the Clear, Conspicuous, and Neutral (CCN) standard. Read the blog to learn more.

09|24|25

Finding the Unfindable: The Artful Ingenuity of AI-Powered Patient Finding

Millions of patients remain undiagnosed or unaware of effective treatments — delaying care and leaving brands with untapped opportunity. Traditional approaches often fall short, but AI-powered patient-finding is changing the game. Our latest POV explores how a strategic combination of diverse data, cross-disciplinary clinical expertise, and advanced AI tools — what we call Artful Ingenuity […]

09|17|25

Decoding the Future of Healthcare: What Patients Want from Their Digital Health Experience

What do patients really want from their digital health experiences? At Fierce Pharma Week 2025, industry leaders tackled this question head-on. Dan Gandor, EVP, Head of Omnichannel & Digital Transformation, delivered a compelling vision for the future, one that places patient needs and expectations at the heart of innovation.

09|10|25

Why Influence Is the New Front Door in Pharma

We’re no longer living in a mass media world—we’re living in a trust economy. That’s the powerful message from Susan Perlbachs, Chief Creative Officer, in her latest article for Med Ad News (PharmaLive). Read more to discover how influence is reshaping the future of pharma marketing. 

09|03|25

Evolving Search Engine Marketing in Pharma: A New Era of Targeting Capabilities

A Google update marks a major shift for pharma marketers, enabling the use of first-party data tools like Customer Match and Remarketing, capabilities previously restricted in sensitive categories. These changes open new doors for precision targeting of HCPs and improved ROI in paid search. Download the POV to learn how your brand can stay competitive in this evolving landscape.

08|28|25

Marketing in the Age of Uncertainty: Preparing for a Post-DTC World

As proposed legislation threatens to ban direct-to-consumer (DTC) pharmaceutical advertising, our experts offer a timely perspective on how pharma marketers can navigate this evolving landscape. In an era defined by regulatory uncertainty and shifting patient expectations, this POV outlines actionable strategies to stay compliant, connected and competitive. Download the POV to discover how marketers can lead the next chapter of healthcare engagement with agility and purpose.

08|20|25

The Evolving Role of GenAI and Search Engine Marketing

AI is rewriting the rules of search, are you ready? Discover how pharma marketers can stay ahead in the GenAI era with smart, adaptable paid search strategies. Access the POV to learn more.

08|15|25

Reimagining Omnichannel: A New Blueprint for Pharma Marketing

Dan Gandor, EVP, Head of Omnichannel and Digital Transformation, is leading the conversation on what modern pharma marketing should look like. In a recent article in Pharmaceutical Commerce, he shared his insights on how omnichannel strategy has evolved, from fragmented tactics to orchestrated, customer-first experiences.  Read the blog to learn more.